163 related articles for article (PubMed ID: 9204460)
1. Retroviral delivery and anti-HIV testing of hammerhead ribozymes.
Cagnon L; Rossi J
Methods Mol Biol; 1997; 74():451-7. PubMed ID: 9204460
[No Abstract] [Full Text] [Related]
2. Ex vivo transduction and expansion of CD4+ lymphocytes from HIV + donors: prelude to a ribozyme gene therapy trial.
Leavitt MC; Yu M; Wong-Staal F; Looney DJ
Gene Ther; 1996 Jul; 3(7):599-606. PubMed ID: 8818647
[TBL] [Abstract][Full Text] [Related]
3. Long-term survival and concomitant gene expression of ribozyme-transduced CD4+ T-lymphocytes in HIV-infected patients.
Macpherson JL; Boyd MP; Arndt AJ; Todd AV; Fanning GC; Ely JA; Elliott F; Knop A; Raponi M; Murray J; Gerlach W; Sun LQ; Penny R; Symonds GP; Carr A; Cooper DA
J Gene Med; 2005 May; 7(5):552-64. PubMed ID: 15655805
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of HIV-1 replication by retroviral vectors expressing monomeric and multimeric hammerhead ribozymes.
Ramezani A; Ding SF; Joshi S
Gene Ther; 1997 Aug; 4(8):861-7. PubMed ID: 9338016
[TBL] [Abstract][Full Text] [Related]
5. Potent inhibition of HIV-1 gene expression and TAT-mediated apoptosis in human T cells by novel mono- and multitarget anti-TAT/Rev/Env ribozymes and a general purpose RNA-cleaving DNA-enzyme.
Unwalla H; Chakraborti S; Sood V; Gupta N; Banerjea AC
Antiviral Res; 2006 Nov; 72(2):134-44. PubMed ID: 16790281
[TBL] [Abstract][Full Text] [Related]
6. Identification and characterization of a highly efficient anti-HIV pol hammerhead ribozyme.
Müller-Kuller T; Capalbo G; Klebba C; Engels JW; Klein SA
Oligonucleotides; 2009 Sep; 19(3):265-72. PubMed ID: 19732019
[TBL] [Abstract][Full Text] [Related]
7. Current developments in anti-HIV/AIDS gene therapy.
Tsygankov AY
Curr Opin Investig Drugs; 2009 Feb; 10(2):137-49. PubMed ID: 19197791
[TBL] [Abstract][Full Text] [Related]
8. Exogenous cellular delivery of ribozymes and ribozyme encoding DNAs.
Castanotto D; Bertrand E; Rossi J
Methods Mol Biol; 1997; 74():429-39. PubMed ID: 9204458
[No Abstract] [Full Text] [Related]
9. Delivery of recombinant HIV-1-directed antisense and ribozyme genes.
Sczakiel G; Palú G; James W
Methods Mol Biol; 1997; 63():389-400. PubMed ID: 9113664
[No Abstract] [Full Text] [Related]
10. Long-term RNase P-mediated inhibition of HIV-1 replication and pathogenesis.
Hnatyszyn H; Spruill G; Young A; Seivright R; Kraus G
Gene Ther; 2001 Dec; 8(24):1863-71. PubMed ID: 11821940
[TBL] [Abstract][Full Text] [Related]
11. An assay system to detect the selective advantage of anti-HIV ribozyme expressing CD4+ T-lymphocytes.
Klein SA; Klebba C; Engels JW
Nucleosides Nucleotides Nucleic Acids; 2001; 20(4-7):629-34. PubMed ID: 11563080
[TBL] [Abstract][Full Text] [Related]
12. siRNAs, ribozymes and RNA decoys in modeling stem cell-based gene therapy for HIV/AIDS.
Akkina R; Banerjea A; Bai J; Anderson J; Li MJ; Rossi J
Anticancer Res; 2003; 23(3A):1997-2005. PubMed ID: 12894572
[TBL] [Abstract][Full Text] [Related]
13. The application of ribozymes to HIV infection.
Rossi JJ
Curr Opin Mol Ther; 1999 Jun; 1(3):316-22. PubMed ID: 11713796
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of HIV-1 replication and infectivity by expression of a fusion protein, VPR-anti-integrase single-chain variable fragment (SFv): intravirion molecular therapies.
BouHamdan M; Kulkosky J; Duan LX; Pomerantz RJ
J Hum Virol; 2000; 3(1):6-15. PubMed ID: 10774802
[TBL] [Abstract][Full Text] [Related]
15. Hairpin ribozyme gene therapy for AIDS.
Duarte EA; Leavitt MC; Yamada O; Yu M
Methods Mol Biol; 1997; 74():459-68. PubMed ID: 9204461
[No Abstract] [Full Text] [Related]
16. Use of adenoviral VAI small RNA as a carrier for cytoplasmic delivery of ribozymes.
Prislei S; Buonomo SB; Michienzi A; Bozzoni I
RNA; 1997 Jun; 3(6):677-87. PubMed ID: 9174101
[TBL] [Abstract][Full Text] [Related]
17. Development and testing of retroviral vectors expressing multimeric hammerhead ribozymes targeted against all major clades of HIV-1.
Ramezani A; Ma XZ; Nazari R; Joshi S
Front Biosci; 2002 Feb; 7():a29-36. PubMed ID: 11815297
[TBL] [Abstract][Full Text] [Related]
18. Technology evaluation: HIV ribozyme gene therapy, Gene Shears Pty Ltd.
de Feyter R; Li P
Curr Opin Mol Ther; 2000 Jun; 2(3):332-5. PubMed ID: 11249628
[TBL] [Abstract][Full Text] [Related]
19. Retrovirally expressed anti-HIV ribozymes confer a selective survival advantage on CD4+ T cells in vitro.
Klebba C; Ottmann OG; Scherr M; Pape M; Engels JW; Grez M; Hoelzer D; Klein SA
Gene Ther; 2000 Mar; 7(5):408-16. PubMed ID: 10694823
[TBL] [Abstract][Full Text] [Related]
20. Progress towards gene therapy for HIV infection.
Yu M; Poeschla E; Wong-Staal F
Gene Ther; 1994 Jan; 1(1):13-26. PubMed ID: 7584055
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
